[go: up one dir, main page]

GR3027598T3 - Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis - Google Patents

Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis

Info

Publication number
GR3027598T3
GR3027598T3 GR980401742T GR980401742T GR3027598T3 GR 3027598 T3 GR3027598 T3 GR 3027598T3 GR 980401742 T GR980401742 T GR 980401742T GR 980401742 T GR980401742 T GR 980401742T GR 3027598 T3 GR3027598 T3 GR 3027598T3
Authority
GR
Greece
Prior art keywords
pct
sec
inhibitors
benzisothiazoles
heterocyclic compounds
Prior art date
Application number
GR980401742T
Other languages
English (en)
Inventor
James F Eggler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR3027598T3 publication Critical patent/GR3027598T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR980401742T 1994-03-28 1998-08-06 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis GR3027598T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21878894A 1994-03-28 1994-03-28
PCT/IB1995/000037 WO1995026346A1 (en) 1994-03-28 1995-01-18 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis

Publications (1)

Publication Number Publication Date
GR3027598T3 true GR3027598T3 (en) 1998-11-30

Family

ID=22816518

Family Applications (1)

Application Number Title Priority Date Filing Date
GR980401742T GR3027598T3 (en) 1994-03-28 1998-08-06 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis

Country Status (11)

Country Link
US (1) US5665749A (el)
EP (1) EP0752990B1 (el)
JP (1) JP2841120B2 (el)
AT (1) ATE169298T1 (el)
CA (1) CA2186513C (el)
DE (1) DE69503890T2 (el)
DK (1) DK0752990T3 (el)
ES (1) ES2119377T3 (el)
FI (1) FI963882A0 (el)
GR (1) GR3027598T3 (el)
WO (1) WO1995026346A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227197B1 (en) * 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
MX2011011517A (es) 2009-04-29 2012-06-19 Amarin Corp Plc Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
US5196419A (en) * 1989-02-28 1993-03-23 Imperial Chemical Industries Plc Heterocyclic cyclic ethers
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
AU637500B2 (en) * 1990-06-21 1993-05-27 Zeneca Limited Bicyclic heterocyclic compounds
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途

Also Published As

Publication number Publication date
ES2119377T3 (es) 1998-10-01
MX9604429A (es) 1997-07-31
WO1995026346A1 (en) 1995-10-05
DK0752990T3 (da) 1999-02-08
CA2186513A1 (en) 1995-10-05
JPH09507678A (ja) 1997-08-05
ATE169298T1 (de) 1998-08-15
JP2841120B2 (ja) 1998-12-24
US5665749A (en) 1997-09-09
DE69503890T2 (de) 1998-12-10
CA2186513C (en) 1999-03-16
DE69503890D1 (de) 1998-09-10
EP0752990A1 (en) 1997-01-15
FI963882A7 (fi) 1996-09-27
FI963882L (fi) 1996-09-27
EP0752990B1 (en) 1998-08-05
FI963882A0 (fi) 1996-09-27

Similar Documents

Publication Publication Date Title
FI945556A0 (fi) Tulehdustenvastaiset 3-aryyli-2-isoksatsoliinijohdannaiset
EG20693A (en) Isoxazoline compounds as antiinflammatory agents
SG155909A1 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
UA87691C2 (en) Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
GR3035821T3 (en) Substituted indoles as phosphodiesterase type iv inhibitors
MXPA02011311A (es) Composicion novedosa.
BG103725A (en) Nicotineamide derivatives
CA2150812A1 (en) Catechol diethers as selective pde iv inhibitors
WO2005019190A3 (en) (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors
WO1998056771A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
JO2250B1 (en) Compounds and methods for treating crisis diseases, allergies and infections
DK0980374T3 (da) Phosphodiesterase 4-inhiberende diazepinoindoloner.
SE9900833D0 (sv) Novel combination
GR3027598T3 (en) Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
TW200635932A (en) New pyridothienopyrimidine derivatives
WO2000033788A3 (en) Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
MY112586A (en) Isoxazoline compounds as 5-lipoxygenase inhibitors